FluDrugStrategy
In this collaborative project Beactica is, together with a number of partners, aiming to discover new classes of antiviral drugs that specifically binds to the influenza A capsid protein.
NeuroCypres
Beactica’s role in this collaborative large-scale integrating project is to discover new classes of drugs targetting Cys-loop receptors, a superfamily of ligand-gated ion channels.
BrainTrain
Beactica participates in this initial training network, ITN, that builds on our knowledge of genome information and that aims to develop a new generation of neuroscientists, contributing to the fight against brain disorders .
